Who we serve
Fundraising prep.
A round, an IPO or a sale is underwritten on the company’s go-to-market story. We make that story true before it is told, so it holds up when investors or buyers look underneath it.
Series A and below.
Investors want proof of a repeatable motion rather than a pitch about one.
At this stage the company has usually sold well to people who already knew the founder, and the question an investor asks is whether it can sell to people who don’t. We find out which parts of the motion repeat and which depend on the founder, then build the brand and the go-to-market system that make the rest repeatable, usually as a growth engagement.
Series B and beyond.
The system has to take the company from one segment to three without breaking.
A go-to-market that worked for the first segment rarely survives the second without changes to the offer, the brand and the sales team. We examine all five systems before the company expands, so the round funds growth rather than repairs.
IPO prep.
Public markets need a go-to-market they can underwrite, which means one that is predictable, documented and run by a permanent team.
We put the Revenue System in order so the numbers hold up to scrutiny, write the playbooks down, and recruit and train the permanent team that will run the go-to-market after we leave.
Exit strategy.
We find what a buyer’s diligence will find before the buyer does, and fix it.
A buyer’s diligence will test whether the earnings are real, whether the market is there and whether the company can sell. The Diagnostic answers the third question first, and the Readout shows a buyer what was found and what was done about it.
The Diagnostic
Start with what is true.
Before a round, an IPO or a sale, the Diagnostic takes eight weeks at a fixed fee of $95,000 and tells you what an investor or a buyer will find.